AnnJi Pharmaceutical Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-353.99	-329.22	-236.65	-198.63
Depreciation & Amortization	44.3	37.74	40.05	41.51
Other Amortization	0.65	0.55	0.38	0.12
Loss (Gain) From Sale of Assets	-0.09	-0.2	-0.34	-
Loss (Gain) From Sale of Investments	4.54	29.42	-	-
Stock-Based Compensation	46.78	48.2	6.66	3.02
Other Operating Activities	-0.47	38.92	-	-0.01
Change in Accounts Receivable	-0.15	0.09	-0.09	-
Change in Inventory	-27.42	-	-	-
Change in Accounts Payable	0.12	-	15.66	4.39
Change in Unearned Revenue	66.65	89.56	1.6	-
Change in Other Net Operating Assets	33.06	17.73	-16.75	9.21
Operating Cash Flow	-186.01	-67.2	-189.49	-140.39
Capital Expenditures	-9.95	-12.04	-1.58	-3.23
Sale of Property, Plant & Equipment	0.09	0.26	0.36	-
Sale (Purchase) of Intangibles	-0.56	-0.35	-0.42	-0.52
Investment in Securities	198	-274	-	100
Other Investing Activities	0.74	-1.9	-	0.39
Investing Cash Flow	188.31	-288.02	-1.65	96.65
Short-Term Debt Repaid	-	-	-	-17.08
Long-Term Debt Repaid	-5.95	-	-2.79	-3.25
Total Debt Repaid	-5.95	-	-2.79	-20.33
Net Debt Issued (Repaid)	-5.95	-	-2.79	-20.33
Issuance of Common Stock	33.02	685.18	70	364.5
Other Financing Activities	1.82	-	-0.16	-
Financing Cash Flow	28.89	685.18	67.05	344.17
Foreign Exchange Rate Adjustments	-	-	0.57	-0.57
Net Cash Flow	31.19	329.96	-123.51	299.85
Free Cash Flow	-195.97	-79.23	-191.07	-143.62
Free Cash Flow Margin	-203.18%	-55.20%	-11750.92%	-10008.22%
Free Cash Flow Per Share	-2.11	-1.02	-2.91	-3.18
Cash Interest Paid	2.25	-	0.03	0.15
Cash Income Tax Paid	-	-0.01	1.59	-0.01
Levered Free Cash Flow	-78.57	93.18	-104.84	-
Unlevered Free Cash Flow	-77.46	93.47	-104.82	-
Change in Net Working Capital	-66.42	-187.25	-0.42	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.